The ABT578-eluting ENDEAVOR stent has been compared head-to-head with sirolimus-eluting Cypher. Duke University’s David Kandzari told us more.
[audio:https://www.audiomedica.com/podcasting/aha2005/David_Kandzari.mp3]
Hydrochlorothiazide: Not Recommended For First-Line Therapy In Hypertension 18 Jun, 2009 
Drug-eluting Stents: No Benefit in Vein Grafts 17 Nov, 2005 
Czech Republic Sees Massive Decline In Cardiovascular Deaths With Hypertension Treatment And Awareness 18 Jun, 2009 Primary PCI: Better in the Real World, Too 17 Nov, 2005 
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014